Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 22244004)

1.

Clinical and laboratory characteristics of children positive for antiphospholipid antibodies.

Giordano P, Tesse R, Lassandro G, Fracchiolla D, Ranieri P, Lotito A, De Mattia D, Del Vecchio GC.

Blood Transfus. 2012 Jul;10(3):296-301. doi: 10.2450/2011.0069-11. Epub 2011 Dec 21.

2.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
3.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

4.
5.

Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A, Gambari PF.

Ann Rheum Dis. 1994 Feb;53(2):140-2.

6.
7.

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.

Harel L, Sandborg C, Lee T, von Scheven E.

J Rheumatol. 2006 Sep;33(9):1873-7.

PMID:
16845706
8.

Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.

de Bandt M, Benali K, Guillevin L, Hachulla E, Job C, Fautrel B, Fournié G, Bonnet C, Fournié B, Le Goff P, Jorgensen C, Meyer O.

J Rheumatol. 1999 Jan;26(1):91-6.

PMID:
9918247
9.

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.

Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E.

Lupus. 2007;16(1):39-45.

PMID:
17283584
10.

Real world experience with antiphospholipid antibody tests: how stable are results over time?

Erkan D, Derksen WJ, Kaplan V, Sammaritano L, Pierangeli SS, Roubey R, Lockshin MD.

Ann Rheum Dis. 2005 Sep;64(9):1321-5. Epub 2005 Feb 24.

11.

Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.

Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.

Ann Rheum Dis. 2008 Mar;67(3):395-401. Epub 2007 Jul 20.

PMID:
17644539
12.

Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis.

Meyer MF, Schnabel A, Schatz H, Gross WL.

Semin Arthritis Rheum. 2001 Aug;31(1):4-11.

PMID:
11503134
14.

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.

Bertolaccini ML, Roch B, Amengual O, Atsumi T, Khamashta MA, Hughes GR.

Br J Rheumatol. 1998 Nov;37(11):1229-32.

15.
16.

Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations.

Favaloro EJ, Reben R, Mohammed S, Koutts J.

Intern Med J. 2012 Apr;42(4):427-34. doi: 10.1111/j.1445-5994.2010.02329.x. Epub 2010 Jul 30.

PMID:
20681961
17.

Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.

Obermoser G, Bitterlich W, Kunz F, Sepp NT.

Int Arch Allergy Immunol. 2004 Oct;135(2):148-53. Epub 2004 Sep 2.

PMID:
15345914
18.
19.

Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.

Cabral AR, Cabiedes J, Alarcón-Segovia D.

Lupus. 2004;13(3):182-7.

PMID:
15119547
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk